Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Getinge

196.35 SEK

-0.41 %

Less than 1K followers

GETI B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
-0.41 %
-10.26 %
-7.95 %
-12.03 %
-0.73 %
-12.42 %
-14.93 %
-11.95 %
+2,379.69 %

Getinge is a global medical technology company specializing in providing equipment and IT systems to the healthcare and life science industries. The company offers solutions for operating rooms, intensive care units, sterilization centers and drug development, among other things. The company was founded in 1904 and is headquartered in Gothenburg.

Read more
Market cap
53.48B SEK
Turnover
480.14M SEK
Revenue
34.97B
EBIT %
10.84 %
P/E
23.69
Dividend yield-%
2.42 %
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
21/4
2026

General meeting '26

21/4
2026

Interim report Q1'26

22/4
2026

Annual dividend

All
Webcasts
Press releases
ShowingAll content types
Getinge, Audiocast, Q4'25
Webcast1/27/2026, 9:00 AM

Getinge, Audiocast, Q4'25

Getinge
Regulatory press release1/27/2026, 7:00 AM

Getinge Q4 and Full-Year Report 2025: Organic growth and solid cash flow to end the year

Getinge
Regulatory press release1/27/2026, 7:00 AM

Getinges Q4 och helårsrapport 2025: Organisk tillväxt och robust kassaflöde avslutade året

Getinge

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release1/22/2026, 1:30 PM

Modular Finance IR Consensus: Getinge – Consensus estimates Q4 2025

Getinge
Regulatory press release1/20/2026, 9:13 AM

Finansinspektionen: Flaggningsmeddelande i Getinge AB

Getinge
Press release1/13/2026, 7:00 AM

Getinge invites fund managers, analysts, and media to Year-End Report 2025 conference call

Getinge
Press release1/13/2026, 7:00 AM

Getinge bjuder in fondförvaltare, analytiker och media till telefonkonferens för helårsrapport 2025

Getinge
Regulatory press release1/5/2026, 2:57 PM

Finansinspektionen: Flaggningsmeddelande i Getinge AB

Getinge
Regulatory press release12/30/2025, 9:30 AM

Finansinspektionen: Flaggningsmeddelande i Getinge AB

Getinge
Regulatory press release12/18/2025, 8:00 AM

Camilla Sylvest is proposed for Getinge AB's Board of Directors

Getinge
Regulatory press release12/18/2025, 8:00 AM

Camilla Sylvest föreslås till Getinge AB:s styrelse

Getinge
Regulatory press release12/4/2025, 10:48 AM

Finansinspektionen: Flaggningsmeddelande i Getinge AB

Getinge
Getinge, Audiocast, Q3'25
Webcast10/21/2025, 8:00 AM

Getinge, Audiocast, Q3'25

Getinge
Regulatory press release10/21/2025, 6:00 AM

Getinges delårsrapport juli-september 2025: Hög organisk försäljningstillväxt och stärkta marginaler trots geopolitisk motvind

Getinge
Regulatory press release10/21/2025, 6:00 AM

Getinge Interim Report July-September 2025: High organic sales growth and stronger margins despite geopolitical headwinds

Getinge
Press release10/16/2025, 2:00 PM

Modular Finance IR Consensus: Getinge – Consensus estimates Q3 2025

Getinge
Press release10/13/2025, 8:00 AM

Getinge's Advanta V12 receives CE Mark for major bridging indications

Getinge
Press release10/13/2025, 8:00 AM

Getinges Advanta V12 får CE-märkning för utökade indikationer

Getinge
Press release10/7/2025, 6:00 AM

Getinge invites fund managers, analysts, and media to Q3 Report 2025 conference call

Getinge
Press release10/7/2025, 6:00 AM

Getinge bjuder in fondförvaltare, analytiker och media till telefonkonferens för Q3-rapport 2025

Getinge
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.